{"id":371851,"title":"Qualifying notice for Bavencio - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:29:37.427000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-bavencio-208742.html","snippet":"Qualifying notice for Bavencio Biologics and Genetic Therapies Directorate 100 Eglantine Driveway Address Locator #0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e196892 Control #: 208742 Document #: 1309699 [employee name removed] [employee title removed] EMD Serono, A Division of…","rawSnapshotUrl":"/api/snapshots/raw/371851","browseUrl":"https://replay.healtharchive.ca/job-6/20260411152937/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-bavencio-208742.html#ha_snapshot=371851","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}